The largest database of trusted experimental protocols

12 protocols using ab serum

1

Isolation and Culture of Human Monocytes and T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human monocyte and T cell cultures were generated from leukapheresis specimens from consenting donors under IRB-approved protocols. Peripheral blood mononuclear cells (PBMCs) were isolated following density gradient centrifugation (Ficoll-Hypaque, GE Healthcare, Uppsala, Sweden) and cryopreserved. Short-term monocyte cultures were established from thawed PBMCs by plastic adherence for 2 hours at 37° C, in RPMI 1640 medium with 10% heat-inactivated AB serum (Life Technologies, Carlsbad, CA). Non-adherent cells were removed by washing to enrich for adherent monocytes. CD3+ T cells were isolated from PBMCs using the MACS Pan T Cell Isolation Kit II (Miltenyi Biotec, Auburn, CA) and cultured in RPMI 1640 medium with 10% heat-inactivated AB serum and cytokines as described below. The melanoma cell lines 537-mel, 1363-mel, and 1558-mel, established from metastatic melanoma specimens as previously described,11 (link) were cultured in RPMI 1640 medium with 10% heat-inactivated FBS (Life Technologies; or Sigma-Aldrich, St. Louis, MO). All cultures were maintained in a 37°C, 5% CO2 incubator.
+ Open protocol
+ Expand
2

Allogeneic T Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Different numbers of DC were cocultured with 100,000 allogeneic T lymphocytes in RPMI containing 5% AB serum, l-glutamine (2 mmol/L), penicillin (50 U/mL), and streptomycin (50 mg/mL; all from Life Technologies). On day 5, 0.5 µCi/0.2 mL [3H]-thymidine (Amersham Pharmacia, Piscataway, NJ, USA) was added. Incorporated radioactivity was quantified after 24 h by means of a beta counter (Perkin Elmer, Gaithersburg, MD, USA).
+ Open protocol
+ Expand
3

CD8+ T cell activation and IFNγ analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated CD8+ T cells from PBMCs (see above) were activated in 96-well plates coated with 5mg/ml plate bound Ultra-LEAF™ anti-CD3 Ab (OKT3, Biolegend) and 2mg/ml plate bound Ultra-LEAF™ anti-CD28 Ab (CD28.2, Biolegend) at a density of 1 × 105 cells per well, in a 1:1 mix of Aim 5 (Gibco) and RPMI medium (Gibco), supplemented with 10% AB serum (Life Technologies), 100 U/ml penicillin (Roche), 100 mg/ml streptomycin (Roche). After 2 h, cells were either left untreated or were treated with 5 nM LCKi inhibitor (Merck Milipore) for the indicated time periods. Cells were subsequently washed 3 times with medium to remove already secreted IFNγ, and cells were then cultured for 3h in 40 ml fresh control medium or fresh medium containing 5 nM LCK inhibitor. Subsequently, supernatants were collected and IFNγ concentrations were determined using the BD™ Cytometric Bead Array (CBA) Human Th1/Th2/Th17 Cytokine Kit, according to the manufacturer’s protocol.
+ Open protocol
+ Expand
4

CD8+ T cell activation and IFNγ analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated CD8+ T cells from PBMCs (see above) were activated in 96-well plates coated with 5mg/ml plate bound Ultra-LEAF™ anti-CD3 Ab (OKT3, Biolegend) and 2mg/ml plate bound Ultra-LEAF™ anti-CD28 Ab (CD28.2, Biolegend) at a density of 1 × 105 cells per well, in a 1:1 mix of Aim 5 (Gibco) and RPMI medium (Gibco), supplemented with 10% AB serum (Life Technologies), 100 U/ml penicillin (Roche), 100 mg/ml streptomycin (Roche). After 2 h, cells were either left untreated or were treated with 5 nM LCKi inhibitor (Merck Milipore) for the indicated time periods. Cells were subsequently washed 3 times with medium to remove already secreted IFNγ, and cells were then cultured for 3h in 40 ml fresh control medium or fresh medium containing 5 nM LCK inhibitor. Subsequently, supernatants were collected and IFNγ concentrations were determined using the BD™ Cytometric Bead Array (CBA) Human Th1/Th2/Th17 Cytokine Kit, according to the manufacturer’s protocol.
+ Open protocol
+ Expand
5

Expansion of Antigen-specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were incubated over night with a mixture of relevant peptides at a concentration of 0.5 µM of each peptide in X-vivo 15 (Fisher Scientific) media supplemented with 5% AB Serum (Invitrogen). The cells were subsequently harvested, washed and plated at a concentration of 5 × 106/ml supplemented with 50U/ml IL-2 for expansion. Fresh media and IL-2 were supplemented every second day until the cells were harvested at day 8, and IL-15 (15ng/ml) was added the last four days.
+ Open protocol
+ Expand
6

PBMC Expansion with Peptide Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were incubated overnight (37°C, 5% CO2) in X-vivo 15 media (Fisher Scientific) supplemented with 5% AB Serum (Invitrogen) and a mixture of relevant peptides at a concentration of 0.5 μM of each peptide. The cells were harvested and washed, and subsequently plated in 24-well plates at a concentration of 5 × 106/ml supplemented with 50 U/ml IL-2 for expansion. Fresh media and IL-2 were supplemented every second day until the cells were harvested at day 8, and IL-15 (15 ng/ml) was added the last 4 days.
+ Open protocol
+ Expand
7

Immune response to bacterial pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
CB mononuclear cells were seeded in 96-well U-bottom plate at 105 cells per well in AIM-V media (Life Technologies) supplemented with 2% AB serum (Invitrogen). The number of monocytes was assumed at 10% of total cells. P. aeruginosa, L. monocytogenes, UPEC, S. typhimurium and A. baumanii were added to the culture at a multiplicity of infection 1 per monocyte and incubated overnight. Cell supernatant was collected and analysed for cytokine production with the multiplex assay (Luminex).
+ Open protocol
+ Expand
8

Activation of T cells and monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy CB cells were seeded in 96-well U-bottom plate at 2 × 105 cells per well in AIM-V media (Life Technologies) supplemented with 2% AB serum (Invitrogen). rhIL-12p40 (BD) and/or rhIFN-α2 (PBL, Piscataway, NJ) were added either alone or in different combinations of concentrations for 24 h and the activation of T cells and monocytes analysed using FACS (BD). The concentrations of rhIL-12p40 tested were 0.1–1,000 ng ml−1 and 0.0004–4 ng ml−1 for rhIFN-α2.
+ Open protocol
+ Expand
9

PBMC Expansion via Peptide Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were incubated overnight (37 o C, 5% CO 2 ) in X-vivo 15 media (Fisher Scientific) supplemented with 5% AB Serum (Invitrogen) and a mixture of relevant peptides at a concentration of 0.5µM of each peptide. The cells were harvested and washed, and subsequently plated in 24-well plates at a concentration of 5 x 10 6 /ml supplemented with 50U/ml IL-2 for expansion. Fresh media and IL-2 were supplemented every second day until the cells were harvested at day 8, and IL-15 (15ng/ml) was added the last four days.
+ Open protocol
+ Expand
10

PBMC Isolation Using Density Gradient

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated by density gradient separation using LymphoPrep (cat #1114547; Axis-Shield, Oslo, Norway) at 1200 x g for 30 minutes, washed twice in phosphate buffered saline followed by centrifugation at 400 x g, and re-suspended in RPMI 1640 (cat #01-106-1a; Biological Industries, Kibbutz Beit Haemek, Israel) containing 30% (v/v) AB serum, 25 mM HEPES, 2 mM L-glutamine (cat #25030–024; Gibco, Life Technologies, Carlsbad, CA), and 50 μg/mL gentamycin sulfate (cat #03-035-1c; Biological Industries). All subsequent centrifugations were carried out at 400 x g. Human serum isolated from healthy male donors of blood group AB (AB serum) was purchased from Lonza (cat # 14-490E; Basel, Switzerland) and used as the serum source in all experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!